vasc Interv 2010;3:267-76.
195. Bergeron P, Pinot JJ, Poyen V, Benichou H, Khanoyan P,
Rudondy P, et al. Long-term results with the Palmaz stent in the
superﬁcial femoral artery. J Endovasc Surg 1995;2:161-7.
196. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM. Three-year results
of the VIBRANT trial of VIABAHN endoprosthesis versus bare
nitinol stent implantation for complex superﬁcial femoral artery
occlusive disease. J Vasc Surg 2013;58:386-95 e4.
197. Kwa AT, Yeo KK, Laird JR. The role of stent-grafts for prevention
and treatment of restenosis. J Cardiovasc Surg (Torino) 2010;51:
579-89.
198. Ahn SS, Concepcion B. Current status of atherectomy for peripheral
arterial occlusive disease. World J Surg 1996;20:635-43.
199. Ambler GK, Radwan R, Hayes PD, Twine CP. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 2014;3:
CD006680.
200. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, Frank U,
et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 2006;48:1573-8.
201. Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M,
et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the
prevention of femoropopliteal restenosis) trial for femoropopliteal
revascularization: ﬁrst-in-human randomized trial of low-dose drugcoated balloon versus